tiprankstipranks
Advertisement
Advertisement

INVA Stock Latest News

Innoviva: Buy Rating Reiterated as LYNX Platform Strengths Support Unchanged $42 Price Target
RatingsInnoviva: Buy Rating Reiterated as LYNX Platform Strengths Support Unchanged $42 Price Target
9d ago
INVA
Innoviva Maintained at Buy as Analyst Highlights Nortiva LYNX Platform Upside, Keeps $46 Price Target Unchanged
PremiumRatings
Innoviva Maintained at Buy as Analyst Highlights Nortiva LYNX Platform Upside, Keeps $46 Price Target Unchanged
10d ago
INVA
Innoviva’s Nortiva Bio launches to develop long-acting oral medicines
PremiumThe Fly
Innoviva’s Nortiva Bio launches to develop long-acting oral medicines
14d ago
INVA
Innoviva announces distribution, licensing agreement with Dr. Reddy’s
PremiumThe Fly
Innoviva announces distribution, licensing agreement with Dr. Reddy’s
16d ago
RDY
INVA
Analyst Reiterates Buy on Innoviva, Maintains $46 Price Target on Strong Earnings and Strategic Investments
PremiumRatings
Analyst Reiterates Buy on Innoviva, Maintains $46 Price Target on Strong Earnings and Strategic Investments
1M ago
INVA
Innoviva Appoints Josephine Linden to Strengthen Board Oversight
PremiumCompany AnnouncementsInnoviva Appoints Josephine Linden to Strengthen Board Oversight
1M ago
8K
INVA
Innoviva management to meet with BTIG
Premium
The Fly
Innoviva management to meet with BTIG
2M ago
INVA
Innoviva management to meet with BTIG
Premium
The Fly
Innoviva management to meet with BTIG
2M ago
INVA
Innoviva price target raised to $42 from $35 at BTIG
PremiumThe Fly
Innoviva price target raised to $42 from $35 at BTIG
2M ago
INVA
Innoviva reports Q1 EPS $2.22 vs (74c) last year
PremiumThe Fly
Innoviva reports Q1 EPS $2.22 vs (74c) last year
2M ago
INVA
Innoviva Shareholders Back Directors, Pay Plan and Incentives
PremiumCompany Announcements
Innoviva Shareholders Back Directors, Pay Plan and Incentives
2M ago
8K
INVA
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
PremiumMarket News
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
4M ago
DEC
ATRC
Innoviva price target raised to $32 from $31 at Cantor Fitzgerald
PremiumThe FlyInnoviva price target raised to $32 from $31 at Cantor Fitzgerald
4M ago
INVA
Innoviva reports Q4 EPS $1.94 vs. 26c last year
Premium
The Fly
Innoviva reports Q4 EPS $1.94 vs. 26c last year
4M ago
INVA
Innoviva initiated with a Buy at BTIG
Premium
The Fly
Innoviva initiated with a Buy at BTIG
4M ago
INVA
Innoviva: Durable Royalty Backbone and High-Growth Hospital Portfolio Underpin Buy Rating and $35 Target
PremiumRatings
Innoviva: Durable Royalty Backbone and High-Growth Hospital Portfolio Underpin Buy Rating and $35 Target
4M ago
INVA
Innoviva price target raised to $46 from $45 at H.C. Wainwright
PremiumThe Fly
Innoviva price target raised to $46 from $45 at H.C. Wainwright
7M ago
INVA
Innoviva Specialty Therapeutics announces FDA approval of Nuzolvence
PremiumThe Fly
Innoviva Specialty Therapeutics announces FDA approval of Nuzolvence
7M ago
INVA
Innoviva’s Zoliflodacin: A Promising Antibiotic Driving Buy Rating Amidst Urgent Need for Drug-Resistant Infection Solutions
PremiumRatings
Innoviva’s Zoliflodacin: A Promising Antibiotic Driving Buy Rating Amidst Urgent Need for Drug-Resistant Infection Solutions
7M ago
INVA
Innoviva announces Lancet publication of ‘positive’ Zoliflodacin Phase 3 data
PremiumThe FlyInnoviva announces Lancet publication of ‘positive’ Zoliflodacin Phase 3 data
7M ago
INVA
Roth Capital healthcare analyst holds an analyst/industry conference call
Premium
The Fly
Roth Capital healthcare analyst holds an analyst/industry conference call
7M ago
BDX
JNJ
Innoviva Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
Innoviva Reports Strong Q3 2025 Financial Results
8M ago
INVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >